Anti-lymphocytic antibody and autoimmune disease: a review.

PubWeight™: 1.53‹?› | Rank: Top 4%

🔗 View Article (PMC 1579119)

Published in Clin Exp Immunol on September 01, 1969

Authors

A M Denman

Articles citing this

Experimental cutaneous leishmaniasis. II. Effects of immunosuppression and antigenic competition on the course of infection with Leishmania enriettii in the guinea-pig. Clin Exp Immunol (1972) 2.15

The selective action of antilymphocyte serum on recirculating lymphocytes: a review of the evidence and alternatives. Clin Exp Immunol (1970) 1.76

Changes in lymphoid populations of ageing CBA and NZB mice. Clin Exp Immunol (1971) 1.31

The effect of anti-lymphocytic IgG on estab- lished autoallergic thyroiditis in rats. Clin Exp Immunol (1969) 0.99

Studies on antilymphocyte antibody in the chicken. I. Effect of rabbit antithymus and antibursa globulin on chicken embryos. Clin Exp Immunol (1970) 0.95

Mikulicz's recurrent oral aphthae: the effect of anti-lymphocyte serum upon the in vitro cytotoxicity of lymphocytes from patients for oral epithelial cells. Clin Exp Immunol (1970) 0.82

Suppression of memory by passive immunization late in the primary response. J Exp Med (1971) 0.77

The effect of anti-lymphocytic antibody on the development of experimental thyroiditis in rats induced by the intra-lymph node injection of rat thyroglobulin in Freund's complete adjuvant. Immunology (1971) 0.75

Antilymphocytic serum--its constitution, effect and mode of action. Proc R Soc Med (1970) 0.75

Editorial: Current status of antilymphocyte globulin. Br Med J (1975) 0.75

Induction of DNA synthesis in lymphocytes from ALG-treated patients. Clin Exp Immunol (1970) 0.75

A technique for detection of agglutinating activity of antilymphocytic serum using formalinized and trypan-blue-stained lymphocytes. Clin Exp Immunol (1970) 0.75

Articles cited by this

(truncated to the top 100)

The origin and kinetics of mononuclear phagocytes. J Exp Med (1968) 14.96

Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc Natl Acad Sci U S A (1966) 12.29

Pathogenesis of the glomerulonephritis of NZB/W mice. J Exp Med (1968) 8.91

Nature and mode of action of antilymphocytic antiserum. Proc Natl Acad Sci U S A (1966) 7.56

The use of heterologous antilymphoid agents in canine renal and liver homotransplantation and in human renal homotransplantation. Surg Gynecol Obstet (1967) 7.24

THE ORIGIN OF MACROPHAGES FROM BONE MARROW IN THE RAT. Br J Exp Pathol (1965) 7.14

The use of specific "lymphocyte" antisera to inhibit hypersensitive reactions of the "delayed" type. J Exp Med (1961) 6.05

Studies on heterologous anti-lymphocyte serum in mice. I. In vitro and in vivo properties. J Immunol (1966) 5.59

Lysis of homologous cells by sensitized lymphocytes in tissue culture. J Natl Cancer Inst (1961) 5.16

THE PRODUCTION OF MACROPHAGES IN THE RAT. Br J Exp Pathol (1965) 4.80

Studies on heterologous anti-lymphocyte serum in mice. II. Effect on the immune response. J Immunol (1966) 4.49

Transfer of allergic encephalomyelitis in rats by means of lymph node cells. J Exp Med (1960) 4.42

The biology of lymphocytic choriomeningitis infection: virus-induced immune disease. Cold Spring Harb Symp Quant Biol (1962) 4.38

Experimental glomerulonephritis. II. Immunologic events in the pathogenesis of nephrotoxic serum nephritis in the rat. J Exp Med (1963) 4.17

THE DEVELOPMENT OF MALIGNANT LYMPHOMA IN THE COURSE OF SJOEGREN'S SYNDROME. Am J Med (1964) 4.07

Lymphocytic choriomeningitis: production of antibody by "tolerant" infected mice. Science (1967) 4.01

THE LYMPHOD TISSUES AND IMMUNE RESPONSES OF NEONATALLY THYMECTOMIZED MICE BEARING THYMUS TISSUE IN MILLIPORE DIFFUSION CHAMBERS. J Exp Med (1964) 3.91

Cytotoxic potential of stimulated human lymphocytes. J Exp Med (1967) 3.89

The effect of anti-lymphocyte globulin on cell-mediated reistance to infection. J Exp Med (1969) 3.84

Central and peripheral effects of anti-lymphocyte sera. Lancet (1967) 3.76

Studies of arthritis and other lesions induced in rats by injection of mycobacterial adjuvant. V. Changes affecting the skin and mucous membranes. Comparison of the experimental process with human disease. J Exp Med (1961) 3.70

Renal transplantation in man. Experience in 35 cases. Lancet (1969) 3.67

PHYTOHAEMAGGLUTININ-INDUCED CYTOTOXIC ACTION OF NORMAL LYMPHOID CELLS ON CELLS IN TISSUE CULTURE. Nature (1964) 3.59

Immunosuppressive therapy. The relation between clinical response and immunologic competence. N Engl J Med (1967) 3.29

Immunological studies on the rat thymectomized in adult life. Immunology (1965) 3.17

Cell to cell interaction in the immune response. IV. Site of action of antilymphocyte globulin. J Exp Med (1968) 3.16

Immunopathology of New Zealand black (NZB) mice. Transplantation (1965) 3.06

Strain differences in the immune response of mice. I. The neonatal response to sheep red cells. Immunology (1968) 2.98

The thymic origin of the plasma lymphocytosis stimulating factor. Br J Cancer (1956) 2.83

THE ROLE OF LYMPHOCYTES IN THE SENSITIZATION OF RATS TO RENAL HOMOGRAFTS. J Exp Med (1965) 2.80

Impaired Lymphocyte Transformation and Delayed Hypersensitivity in Sjögren's Syndrome. J Clin Invest (1967) 2.77

Bone marrow as a source of cells in reactions of cellular hypersensitivity. I. Passive transfer of tuberculin sensitivity in syngeneic systems. J Exp Med (1968) 2.77

Anti-lymphocytic antibody--a review. Clin Exp Immunol (1967) 2.75

The appearance of immunological competence at an early age in New Zealand black mice. Clin Exp Immunol (1968) 2.73

Clinical reactions and serologic changes after the administration of heterologous antilymphocyte globulin to human recipients of renal homografts. Ann Intern Med (1968) 2.72

Radioautographic study of cellular mechanisms in delayed hypersensitivity. I. Delayed reactions to tuberculin and purified proteins in the rat and guinea-pig. Immunology (1963) 2.67

Effects of antilymphocyte serum on virus oncogenesis. Proc Soc Exp Biol Med (1968) 2.63

Immunopathology of NZB/BL mice. VI. Virus separable from spleen and pathogenic for Swiss mice. J Exp Med (1967) 2.53

Autoimmune disease in NZB-Bl mice. II. Autoimmunity and malignant lymphoma. Blood (1966) 2.51

Deficient immunologic functions of NZB mice. Proc Soc Exp Biol Med (1968) 2.41

Effect of antilymphocytic serum on the survival of renal homotransplants in dogs. Transplantation (1966) 2.38

The role of lymphocytes in antibody formation. II. The influence of lymphocyte migration on the initiation of antibody formation in the isolated, perfused spleen. Proc R Soc Lond B Biol Sci (1967) 2.34

Azathioprine (Imuran) administration and the development of malignant lymphomas in NZB mice. Clin Exp Immunol (1968) 2.34

Further experiments on the action of antilymphocytic antiserum. Proc Natl Acad Sci U S A (1967) 2.31

Immunopathology of lymphocytic choriomeningitis viurs infection of newborn mice. Antithymocyte serum effects on glomerulonephritis and wasting disease. J Exp Med (1968) 2.31

Erythrocyte survival in normal mice and in mice with autoimmune haemolytic anaemia. Clin Exp Immunol (1966) 2.29

Glomerular basement membrane damage in immunological glomerulonephritis. Immunology (1968) 2.29

Suppression of adjuvant disease in the rat by heterologous antilymphocyte globulin. J Exp Med (1968) 2.27

The dual necessity for delayed hypersensitivity and circulating antibody in the pathogenesis of experimental allergic orchitis in guinea-pigs. Immunology (1967) 2.26

Suppression of experimentally induced polyarthritis in the rat by heterologous anti-lymphocyte serum. Lancet (1966) 2.19

An analysis of the effects of some types of anti-lymphocyte sera on contact hypersensitivity and certain models of inflammation. Immunology (1968) 2.07

Induction of DNA synthesis in normal human lymphocyte cultures by antigen-antibody complexes. Clin Exp Immunol (1969) 2.03

Immunosuppressive potency and in-vitro activity of antilymphocyte globulin. Lancet (1969) 2.02

Mode of action of anti-lymphocyte globulin. I. The distribution of rabbit anti-lymphocyte globulin injected into rats and mice. Immunology (1968) 1.98

Cross-reaction of anti-lymphocyte serum with haemopoietic stem cells. Nature (1968) 1.97

Enhancing effect of antilymphocytic serum on mycobacterial infections in mice. Nature (1968) 1.97

Notes on the preparation and assay of anti-lymphocytic serum for use in mice. Immunology (1968) 1.96

Suppression of allergic encephalomyelitis in rats by means of antibrain serum. J Exp Med (1963) 1.96

RADIOAUTOGRAPHIC STUDY OF CELLULAR MECHANISMS IN DELAYED HYPERSENSITIVITY. II. EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS IN THE RAT. J Neuropathol Exp Neurol (1963) 1.95

Effects of anti-lymphoid sera on viral infections. Lancet (1968) 1.87

Preparation of lymphocyte-specific antibody from anti-lymphocyte serum. Lancet (1968) 1.85

Cytotoxicity of human lymphocytes: antagonism between inducing processes. Nature (1968) 1.76

Effects of anti-thymocyte serum on lymphocytic choriomeningitis (LCM) virus infection in mice. Proc Soc Exp Biol Med (1967) 1.71

Cyclophosphamide treatment of renal disease in (NZB x NZW) F1 hybrid mice. Lancet (1968) 1.70

Bone marrow as source of cells in reactions of cellular hypersensitivity. II. Identification of allogeneic or hybrid cells by immunofluorescence in passively transferred tuberculin reactions. J Exp Med (1968) 1.69

The initial lesion in experimental allergic neuritis. A phase and electron microscopic study. J Exp Med (1968) 1.68

Antigenicity in mice of antilymphocyte gamma-globulin. Nature (1967) 1.67

Some effects of purified heterologous antihuman lymphocyte serum in man. Transplantation (1967) 1.62

Histopathological effects in mice of heterologous antilymphocyte serum. J Exp Med (1968) 1.61

Passive transfer of transplantation immunity. III. Inbred guinea pigs. J Exp Med (1963) 1.60

Effect of antilymphocyte serum on the growth of Hep 2 and HeLa cells in mice. Nature (1968) 1.58

Suppression of Coombs-positive haemolytic anaemia in NZB mice by antilymphocyte globulin. Lancet (1967) 1.57

Renal transplantation in the inbred rat. 3. A study of heterologous anti-thymocyte sera. J Exp Med (1967) 1.57

STUDIES OF IMMUNE DESTRUCTION OF LYMPHOID TISSUE. I. LYMPHOCYTOTOXIC EFFECT OF RABBIT-ANTI-RAT-LYMPHOCYTE ANTISERUM. Transplantation (1964) 1.56

Testing of anti-human lymphocyte sera in chimpanzees and lower primates. Lancet (1968) 1.55

The immune response in NZB and NZB x C3H F1-hybrid mice as measured by the haemolysin plaque technique. Int Arch Allergy Appl Immunol (1966) 1.55

The effects of heterologous anti-thymocyte sera in mice. I. The use of a graft-vs.-host assay as a measure of homograft reactivity. J Immunol (1968) 1.53

Malignant changes in New Zealand black mice. Clin Exp Immunol (1967) 1.52

Effects of heterologous anti-lymphocyte serum on the distribution of 51-Cr-labelled lymph node cells in mice. Immunology (1968) 1.52

Site of action of antilymphocyte globulin. Lancet (1967) 1.51

Particles resembling murine leukaemia virus in New Zealand black mice. Clin Exp Immunol (1968) 1.50

Experimental immune inflammation in the synovial membrane. I. The immunological mechanism. Immunology (1968) 1.49

Mode of action of anti-lymphocyte globulin. II. Changes in the lymphoid cell population in rats treated with anti-lymphocyte globulin. Immunology (1968) 1.49

Resistance of long-lived lymphocytes and plasma cells in rat lymph nodes to treatment with prednisone, cyclophosphamide, 6-mercaptopurine, and actinomycin D. J Exp Med (1967) 1.49

The transfer of allergic thyroiditis in histocompatible guinea pigs by lymph node cells. J Immunol (1967) 1.48

Time-dependent immunosuppressive effects of anti-thymocyte serum. Nature (1967) 1.48

The origin of mononuclear cells in chronic inflammation and tuberculin reactions in the rat. J Pathol Bacteriol (1968) 1.47

The effect of peripheral lymphocytes from patients with inflammatory joint disease on human target cells in vitro. Clin Exp Immunol (1968) 1.46

Studies on immunological tolerance to LCM virus. A preliminary report on adoptive immunization of virus carrier mice. Acta Pathol Microbiol Scand (1962) 1.46

The provocation of latent lymphocytic choriomeningitis virus infections in mice by treatment with antilymphocytic serum. J Exp Med (1968) 1.46

Aplastic anemia, histiocytosis and erythrodermia in immunologically deficient children. Probable human runt disease. N Engl J Med (1965) 1.46

A study of the effects of anti-macrophage sera. Immunology (1969) 1.44

Destruction of human cells in tissue culture by lymphocytes from patients with systemic lupus erythematosus. Lancet (1966) 1.43

Lupus nephritis: varying complement-fixing properties of immunoglobulin G antibodies to antigens of cell nuclei. Science (1968) 1.41

Mode of action for anti-lymphocyte serum. Nature (1968) 1.37

The use of subcellular fractions to raise anti-lymphocytic serum. Immunology (1968) 1.36

Cellular immunity in vaccinia infection of mice. Anti-thymocyte serum effects on primary and secondary responsiveness. J Exp Med (1968) 1.36

The effect of heterologous antisera and rheumatoid factor on the synthesis of DNA and protein by human peripheral lymphocytes. Immunochemistry (1966) 1.35

STUDIES ON IMMUNOLOGICAL TOLERANCE TO LCM VIRUS. 5. THE INDUCTION OF TOLERANCE TO THE VIRUS. Acta Pathol Microbiol Scand (1965) 1.33

SUPPRESSION OF PLASMA CELL HEPATITIS WITH 6-MERCAPTOPURINE. Am J Med (1964) 1.33

Articles by these authors

(truncated to the top 100)

Cooperating and controlling functions of thymus-derived lymphocytes in relation to autoimmunity. Lancet (1971) 7.98

Systemic lupus erythematosus syndrome induced by practolol. Br Med J (1973) 6.59

The lymphocyte transformation test and gold hypersensitivity. Ann Rheum Dis (1968) 3.54

Failure of cytotoxic drugs to suppress immune responses of patients with rheumatoid arthritis. Ann Rheum Dis (1970) 2.42

Changes in the life-span of circulating small lymphocytes in mice after treatment with anti-lymphocyte globulin. Lancet (1968) 2.21

Mode of action of anti-lymphocyte globulin. I. The distribution of rabbit anti-lymphocyte globulin injected into rats and mice. Immunology (1968) 1.98

Neurological complications in Behçet's syndrome. Brain (1999) 1.68

Anticardiolipin antibodies: occurrence in Behçet's syndrome. Ann Rheum Dis (1984) 1.61

Suppression of Coombs-positive haemolytic anaemia in NZB mice by antilymphocyte globulin. Lancet (1967) 1.57

Chronic myelocytic leukemia. Origin of some lymphocytes from leukemic stem cells. J Clin Invest (1978) 1.55

Mode of action of anti-lymphocyte globulin. II. Changes in the lymphoid cell population in rats treated with anti-lymphocyte globulin. Immunology (1968) 1.49

Virus infections of lympho-reticular cells and auto-immune diseases. Transplant Rev (1976) 1.45

Depletion of long-lived lymphocytes in old New Zealand black mice. Clin Exp Immunol (1970) 1.44

Susceptibility of human lymphocyte populations to infection by herpes simplex virus. Immunology (1977) 1.37

Inactivation of myxoviruses by lymphoid cells. J Gen Virol (1973) 1.33

Control mechanisms in infectious mononucleosis. Clin Exp Immunol (1974) 1.29

Effect of anti-lymphocyte globulin on kidney disease in (N.Z.B. x N.Z.W.) F 1 mice. Lancet (1966) 1.27

Lymphocyte abnormalities in Behçet's syndrome. Clin Exp Immunol (1980) 1.20

The Guillain-Barré syndrome following Campylobacter enteritis with recovery after plasmapheresis. J Infect (1983) 1.18

A new manifestation of infection with Epstein-Barr virus. Br Med J (1978) 1.14

Defective B cell function in systemic lupus erythematosus. Clin Exp Immunol (1982) 1.13

Thrombosis in Behçet's disease: a retrospective survey from a single UK centre. Rheumatology (Oxford) (2001) 1.11

Adoptive transfer of the diseases of New Zealand black mice to normal mouse strains. Clin Exp Immunol (1969) 1.08

Studies of the effect of induced immune lymphopenia. I. Enhanced effects of rabbit anti-rat lymphocyte globulin in rats tolerant to rabbit immunoglobulin G. J Immunol (1967) 1.08

Infection and interferon production in systemic juvenile chronic arthritis: a prospective study. Ann Rheum Dis (1984) 1.07

Lymphokine-activated killer cell activity in rheumatoid arthritis. Clin Exp Immunol (1987) 1.05

Inactivation of influenza virus by human lymphocytes. Clin Exp Immunol (1974) 1.04

Herpes simplex virus depresses antibody production by affecting T-cell function. Nature (1980) 1.04

Chlorambucil-induced chromosome damage to human lymphocytes is dose-dependent and cumulative. Lancet (1984) 1.02

Radiosensitivity of peripheral blood lymphocytes in autoimmune disease. Int J Radiat Biol Relat Stud Phys Chem Med (1985) 1.01

Fate of herpes simplex virus in lymphocytes from inflammatory joint effusions. i. Failure of the virus to grow in cultured lymphocytes. Ann Rheum Dis (1979) 1.01

Interferon-gamma production by peripheral blood mononuclear cells from patients with Behçet's syndrome. Clin Exp Immunol (1984) 1.01

Termination of acquired tolerance by administration of small lymphocytes. J Immunol (1967) 1.01

Replication or inactivation of different viruses by human lymphocyte preparations. Infect Immun (1974) 0.99

Intensive immunosuppression versus prednisolone in the treatment of connective tissue diseases. Ann Rheum Dis (1982) 0.97

Cyclosporin A in the treatment of severe Behçet's uveitis. Br J Rheumatol (1987) 0.97

Self-tolerance and autoimmunity. Br Med Bull (1976) 0.97

Defective repair of 0(6)-methylguanine in autoimmune diseases. Lancet (1982) 0.96

Immunodeficiency and general medicine. Br Med J (1980) 0.95

Pregnancy and immunological disorders. Br Med J (Clin Res Ed) (1982) 0.94

The rheumatoid synovial membrane participates in systemic anti-viral immune responses. Clin Exp Immunol (1985) 0.93

Interferon system in patients with systemic juvenile chronic arthritis: in vivo and in vitro studies. Clin Exp Immunol (1983) 0.93

Measruement of immunological function in man: interaction between virus and human leukocytes. Proc R Soc Med (1974) 0.93

Fate of herpes simplex virus in lymphocytes from inflammatory joint effusions. ii. Mechanisms of non-permissiveness. Ann Rheum Dis (1979) 0.93

The viral theory of connective tissue diseases: a review. Med Biol (1975) 0.93

A search for retrovirus infection in systemic lupus erythematosus and rheumatoid arthritis. Ann Rheum Dis (1988) 0.90

2',5'-oligoadenylate synthetase induction in lymphocytes of patients with connective tissue diseases. Ann Rheum Dis (1986) 0.89

Review: method of separating human blood lymphoid cell populations. J Immunol Methods (1973) 0.89

Normal induction and maintenance of tolerance in (NZBxNZW) F1 mice. Clin Exp Immunol (1969) 0.89

Improved graft survival after treatment with Bordetella and anti-lymphocyte serum. Nature (1969) 0.88

Autoimmune disease in inbred mice. Clin Exp Immunol (1967) 0.88

Spontaneous production of B cell growth factors by SLE lymphocytes. Clin Exp Immunol (1987) 0.87

Intensive immunosuppression in intractable rheumatoid arthritis. Br J Rheumatol (1986) 0.87

The treatment of connective tissue diseases with antilymphocyte globulin. Postgrad Med J (1976) 0.86

Nature and diagnosis of food allergy. Proc Nutr Soc (1979) 0.86

Cytokine-independent progression of immunoglobulin production in vitro by B lymphocytes from patients with systemic lupus erythematosus. Clin Exp Immunol (1991) 0.86

Malignancies induced by chlorambucil. Cancer Treat Rev (1984) 0.85

Selective immunosuppressive effects of measles virus infection. Clin Exp Immunol (1982) 0.85

Activation of IL-6 production by UV irradiation of blood mononuclear cells from patients with systemic lupus erythematosus. Clin Exp Immunol (1992) 0.85

Lymphocyte function and virus infections. J Clin Pathol Suppl (R Coll Pathol) (1979) 0.85

Treatment with acyclovir does not affect orogenital ulcers in Behçet's syndrome: a randomized double-blind trial. Br J Rheumatol (1988) 0.84

Immunopathology of New Zealand Black mice treated with antilymphocyte globulin. Immunology (1971) 0.84

Renal disease in (NZB x NZW)F1 hybrid mice treated with anti-lymphocytic antibody. Clin Exp Immunol (1970) 0.83

Increased sensitivity of lymphocytes from patients with systemic autoimmune diseases to DNA alkylation by the methylating carcinogen N-methyl-N-nitrosourea. Ann Rheum Dis (1988) 0.83

Immunoregulatory effects of interferon-alpha. I. Interferon-alpha inhibits in vitro antibody synthesis by normal human lymphocytes. Clin Exp Immunol (1985) 0.82

Endothelial prostacyclin release in systemic lupus erythematosus. Thromb Haemost (1989) 0.82

Immunity and depression. Br Med J (Clin Res Ed) (1986) 0.82

Induction of antibody synthesis in cultures of human lymphoid cells. Int Arch Allergy Appl Immunol (1973) 0.81

Retroperitoneal fibrosis and polyarteritis nodosa successfully treated by intensive immunosuppression. J R Soc Med (1980) 0.81

Lymphocyte responses in juvenile chronic arthritis and Behçet's disease--cell number requirements and effects of glucocorticosteroid therapy. Clin Exp Immunol (1982) 0.80

Inflammatory disorders of muscle. Aetiology. Clin Rheum Dis (1984) 0.80

Rheumatoid arthritis--a virus disease? J Clin Pathol Suppl (R Coll Pathol) (1978) 0.79

Rheumatoid arthritis in a patient with primary hypogammaglobulinaemia. Br J Rheumatol (1993) 0.79

Scleroderma treated with immunosuppressive drugs. Br J Dermatol (1979) 0.79

Rheumatoid arthritis. Aetiology. Br Med J (1970) 0.79

Sister-chromatid exchange frequencies in fibroblasts and lymphocytes of patients with systemic lupus erythematosus. Mutat Res (1987) 0.78

Cyclophosphamide induces more chromosome damage than chlorambucil in patients with connective tissue diseases. Q J Med (1986) 0.77

Lymphocyte function and disease. Br Med J (1978) 0.77

A rare mediastinal tumour presenting with systemic effects due to IL-6 and tumour necrosis factor (TNF) production. Clin Exp Immunol (1995) 0.77

Sensitivity of lymphocytes from patients with systemic lupus erythematosus to the induction of sister chromatid exchanges by alkylating agents and bromodeoxyuridine. Ann Rheum Dis (1987) 0.77

A viral aetiology for juvenile chronic arthritis? Br J Rheumatol (1988) 0.77

Cryoglobulins and the immunopathological manifestations of autoimmune disease. Clin Exp Immunol (1992) 0.76

Infection with Epstein-Barr virus. Br Med J (1979) 0.75

Sex hormones, autoimmune diseases, and immune responses. BMJ (1991) 0.75

Control of house dust mite antigen in bedding. Lancet (1990) 0.75

Abnormal lymphocyte function is secondary to drug-induced autoimmunity. Ann Rheum Dis (1976) 0.75

AIDS and CFS/ME. Clin Med (2003) 0.75

What is clinical immunology? J Clin Pathol (1981) 0.75

Anti-thymocyte globulin in scleroderma. Rheumatology (Oxford) (2001) 0.75

Thrombophlebitis migrans following co-trimoxazole therapy. Postgrad Med J (1989) 0.75

Fate of herpes simplex virus in lymphocytes from blood and joint effusions of systemic and pauciarticular juvenile chronic arthritis. Ann Rheum Dis (1983) 0.75

Graft-versus-host disease. Br Med J (Clin Res Ed) (1982) 0.75

Removal of lymphocytes in rheumatoid arthritis. Br Med J (Clin Res Ed) (1981) 0.75

Sister-chromatid exchange frequencies in lymphocytes of controls and patients with connective tissue diseases. Mutat Res (1986) 0.75

Response of the thymus and immunologically induced lymphopenia. Proc Soc Exp Biol Med (1967) 0.75

Renal disease in (NZB x NZW) F1 mice treated with antilymphocytic antibody. II. Effects of restoration with isogeneic, allogeneic, and xenogeneic lymphoid cells. Clin Exp Immunol (1970) 0.75

Chlorambucil induced chromosome damage in juvenile chronic arthritis. Arch Dis Child (1985) 0.75

Systemic lupus erythematosus presenting as morbid jealousy. Postgrad Med J (1980) 0.75

Sister chromatid exchange frequencies in patients with scleroderma and their relatives. Ann Rheum Dis (1986) 0.75

Immunoregulatory effects of alpha-interferon. Effects on in-vitro antibody synthesis by lymphocytes from patients with rheumatoid arthritis. Ann Rheum Dis (1985) 0.75